Literature DB >> 20582541

FDG-PET for early assessment of Alzheimer's disease: isn't the evidence base large enough?

Giovanni Lucignani1, Flavio Nobili.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20582541     DOI： 10.1007/s00259-010-1535-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  18 in total

1.  The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.

Authors:  William J Jagust; Dan Bandy; Kewei Chen; Norman L Foster; Susan M Landau; Chester A Mathis; Julie C Price; Eric M Reiman; Daniel Skovronsky; Robert A Koeppe
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 2.  Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline.

Authors:  G Waldemar; B Dubois; M Emre; J Georges; I G McKeith; M Rossor; P Scheltens; P Tariska; B Winblad
Journal:  Eur J Neurol       Date:  2007-01       Impact factor: 6.089

3.  Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Kewei Chen; Jessica B S Langbaum; Adam S Fleisher; Napatkamon Ayutyanont; Cole Reschke; Wendy Lee; Xiaofen Liu; Dan Bandy; Gene E Alexander; Paul M Thompson; Norman L Foster; Danielle J Harvey; Mony J de Leon; Robert A Koeppe; William J Jagust; Michael W Weiner; Eric M Reiman
Journal:  Neuroimage       Date:  2010-03-02       Impact factor: 6.556

Review 4.  Autopsy as gold standard in FDG-PET studies in dementia.

Authors:  Pascali Durand-Martel; Dominic Tremblay; Catherine Brodeur; Nancy Paquet
Journal:  Can J Neurol Sci       Date:  2010-05       Impact factor: 2.104

5.  Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study.

Authors:  Silvia Morbelli; Arnoldo Piccardo; Giampiero Villavecchia; Barbara Dessi; Andrea Brugnolo; Alessandra Piccini; Anna Caroli; Giovanni Frisoni; Guido Rodriguez; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

6.  Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis.

Authors:  F Clerici; A Del Sole; A Chiti; L Maggiore; M Lecchi; S Pomati; L Mosconi; G Lucignani; C Mariani
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-10-07       Impact factor: 2.346

7.  Relationships between biomarkers in aging and dementia.

Authors:  W J Jagust; S M Landau; L M Shaw; J Q Trojanowski; R A Koeppe; E M Reiman; N L Foster; R C Petersen; M W Weiner; J C Price; C A Mathis
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

8.  Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Jessica B S Langbaum; Kewei Chen; Wendy Lee; Cole Reschke; Dan Bandy; Adam S Fleisher; Gene E Alexander; Norman L Foster; Michael W Weiner; Robert A Koeppe; William J Jagust; Eric M Reiman
Journal:  Neuroimage       Date:  2009-01-21       Impact factor: 6.556

9.  Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.

Authors:  K B Walhovd; A M Fjell; J Brewer; L K McEvoy; C Fennema-Notestine; D J Hagler; R G Jennings; D Karow; A M Dale
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

10.  Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.

Authors:  Rachel Mistur; Lisa Mosconi; Susan De Santi; Marla Guzman; Yi Li; Wai Tsui; Mony J de Leon
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077
View more
  4 in total

1.  Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.

Authors:  Christian Habeck; Shannon Risacher; Grace J Lee; M Maria Glymour; Elizabeth Mormino; Shubhabrata Mukherjee; Sungeun Kim; Kwangsik Nho; Charles DeCarli; Andrew J Saykin; Paul K Crane
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

Authors:  Jean-Paul Soucy; Robert Bartha; Christian Bocti; Michael Borrie; Amer M Burhan; Robert Laforce; Pedro Rosa-Neto
Journal:  Alzheimers Res Ther       Date:  2013-07-08       Impact factor: 6.982

3.  Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study.

Authors:  M Pagani; F De Carli; S Morbelli; J Öberg; A Chincarini; G B Frisoni; S Galluzzi; R Perneczky; A Drzezga; B N M van Berckel; R Ossenkoppele; M Didic; E Guedj; A Brugnolo; A Picco; D Arnaldi; M Ferrara; A Buschiazzo; G Sambuceti; F Nobili
Journal:  Neuroimage Clin       Date:  2014-11-18       Impact factor: 4.881

4.  Impulsivity is Associated with Increased Metabolism in the Fronto-Insular Network in Parkinson's Disease.

Authors:  Masoud Tahmasian; Luisa Rochhausen; Franziska Maier; Kim L Williamson; Alexander Drzezga; Lars Timmermann; Thilo Van Eimeren; Carsten Eggers
Journal:  Front Behav Neurosci       Date:  2015-11-30       Impact factor: 3.558
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.